Reply: GDNF poses troubling questions for doctors, drug maker.
Slevin
John T
JT
Gerhardt
Greg A
GA
Smith
Charles D
CD
Gash
Don M
DM
Young
A Byron
AB
D002986:Clinical Trials as Topic; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D012107:Research Design
D051100:Glial Cell Line-Derived Neurotrophic Factor